Assessment of the quality of cervical mucus among users of the levonorgestrel-releasing intrauterine system at different times of use

Eur J Contracept Reprod Health Care. 2016 Aug;21(4):318-22. doi: 10.1080/13625187.2016.1193139. Epub 2016 Jun 7.

Abstract

Background and objectives: The quality of cervical mucus (CM) among the levonorgestrel-releasing intrauterine system (LNG-IUS) users is controversial. The objectives were to assess CM compared to the levels of oestradiol (E2) and the frequency of cycles with luteal activity among users of the LNG-IUS.

Materials and methods: In total, 224 LNG-IUS users for between two months and five years were recruited at a Brazilian family planning clinic. For the cross-sectional part of the study, we enrolled 175 LNG-IUS users at 2, 6 12, 24, 36, 48, and 60 months after insertion (25 women in each group), and we performed one evaluation. For the prospective part of the study, we enrolled 49 LNG-IUS users at the same lengths of use after insertion (7 women in each group), and we evaluated these women once a week for five consecutive weeks. .

Results: Mean (± SEM) CM scores of all evaluations among women with single and weekly evaluations were between 3.3 ± 0.9 and 8.5 ± 0.3, respectively independently of the length of use of the LNG-IUS. Mean E2 values ranged from 45.5 ± 6.8 to 472.5 ± 34.7 pg/ml and the maximum ovarian follicle diameter on the days of evaluation varied from 14.0 ± 1.3 to 31.2 ± 0.4 mm.

Conclusions: The mean CM score of all evaluations, independent of the length of use of the LNG-IUS and normal levels of serum E2, was below 10 was according to the WHO is inadequate for sperm penetration.

Keywords: Cervical mucus; levonorgestrel-releasing intrauterine system; ovulation.

MeSH terms

  • Adult
  • Brazil
  • Cervix Mucus / physiology*
  • Contraceptive Agents, Female / administration & dosage*
  • Contraceptive Agents, Female / blood
  • Cross-Sectional Studies
  • Estradiol / blood
  • Female
  • Humans
  • Intrauterine Devices, Medicated*
  • Levonorgestrel / administration & dosage*
  • Levonorgestrel / blood
  • Ovarian Follicle / physiology
  • Prospective Studies
  • Time Factors

Substances

  • Contraceptive Agents, Female
  • Estradiol
  • Levonorgestrel